Diabetic Ketoacidosis Associated with Sodium-Glucose Cotransporter 2 Inhibitors: Clinical and Biochemical Characteristics of 29 Cases.
與鈉葡萄糖共轉運輸蛋白2抑制劑相關的糖尿病酮酸中毒:29例病例的臨床和生化特徵。
Int J Endocrinol 2024-04-09
Diabetic Ketoacidosis as an Effect of Sodium-Glucose Cotransporter 2 Inhibitor: Real World Insights.
SGLT2 抑制劑導致的糖尿病酮酸中毒:現實世界的洞察。
Diabetes Metab J 2024-06-10
Euglycemic Diabetic Ketoacidosis, Recurrent Genital Abscess, and Proximal Renal Tubular Acidosis With Concurrent SGLT-2 Inhibitor: More Than an Association.
正常血糖性糖尿病酮酸中毒、反覆生殖器膿腫及近端腎小管酸中毒與同時使用 SGLT-2 抑制劑:不僅僅是關聯。
Cureus 2024-09-23
A Case of Euglycemic Diabetic Ketoacidosis Associated With a Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitor.
一例與鈉-葡萄糖共轉運蛋白-2 (SGLT2) 抑制劑相關的正常血糖性糖尿病酮症酸中毒病例。
Cureus 2025-01-09
Euglycemic diabetic ketoacidosis: Rising incidence, diagnostic delays, and the impact of SGLT2 inhibitors in hospitalized patients.
正常血糖性糖尿病酮症酸中毒:發生率上升、診斷延遲及 SGLT2 抑制劑對住院病患的影響。
J Hosp Med 2025-02-19